Klion

Metronidazole, the active ingredient in Klion, is a nitroimidazole antibiotic presented as a vaginal formulation for local use. It is employed to treat bacterial vaginosis and trichomoniasis in women, targeting anaerobic microorganisms that cause these infections and alleviate symptoms through direct application in the vaginal canal.

GNH USA supplies Klion as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with capabilities for bulk manufacturing, quality assurance, and regulatory compliance across EU and global markets.

Metronidazole is used to treat infections caused by anaerobic bacteria and protozoa in the vaginal tract. - Bacterial vaginosis: restores normal vaginal flora by eliminating anaerobic bacteria. - Trichomoniasis: eradicates Trichomonas vaginalis, relieving discharge and irritation. - Anaerobic bacterial vaginitis: reduces pathogenic anaerobes and improves symptoms.

Metronidazole may cause local and systemic adverse reactions.

Common Side Effects: - Vaginal irritation: mild burning or itching at the site of application. - Abnormal discharge: temporary change in color or consistency. - Odor: unpleasant smell from the vaginal area. - Burning sensation: during or after insertion. - Dryness: reduced vaginal moisture. - Mild headache: occasional transient headache.

Serious or Rare Side Effects: - Allergic reaction: rash, hives, or swelling requiring medical attention. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatotoxicity: signs of liver injury such as jaundice. - Neurological effects: seizures or peripheral neuropathy. - Severe gastrointestinal upset: persistent vomiting or abdominal pain. - Hematologic changes: unexplained bruising or bleeding.

Before using Klion, consider the following safety measures. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: discuss potential risks with a physician. - Allergy: avoid if known hypersensitivity to metronidazole or nitroimidazoles. - Alcohol consumption: refrain from alcohol to prevent a disulfiram‑like reaction. - Concurrent vaginal products: avoid using other intravaginal medications simultaneously. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Metronidazole can interact with several medicines; monitor accordingly.

Major Interactions (Avoid): - Alcohol: may cause severe flushing, nausea, and vomiting. - Warfarin: increased anticoagulant effect, risk of bleeding. - Lithium: heightened lithium toxicity.

Moderate Interactions (Monitor Closely): - Cimetidine: may raise metronidazole plasma levels. - Phenobarbital: may reduce metronidazole effectiveness. - Oral contraceptives: possible reduction in contraceptive efficacy.